| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 78 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $31.68M | - | |
| VP | 113.7K | $9.14M | -10,462 | |
| CFO | 90.3K | $7.26M | - | |
| Other | 80.1K | $6.44M | - | |
| VP | 79.1K | $6.36M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2021 | Utter Christine Marie58 | SVP, Finance &CAO | Sell | 316 | $62.37 | $19,708.92 | -3.2% | |
| Jan 5, 2021 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sell | 626 | $62.37 | $39,043.62 | -2.0% | |
| Jan 4, 2021 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sale+OE | 104,038 | $60.58 | $6,302,557.00 | -24.1% | |
| Dec 30, 2020 | Peltz Stuart Walter57 | Chief Executive Officer | Sale+OE | 285,718 | $61.74 | $17,641,458.58 | -39.5% | |
| Dec 14, 2020 | Reeve Emma81 | Director | Sale+OE | 1,972 | $68.00 | $134,096.00 | -37.4% | |
| Dec 8, 2020 | Okey Stephanie56 | Director | Sell | 687 | $62.52 | $42,953.99 | -41.6% | |
| Dec 7, 2020 | Peltz Stuart Walter57 | Chief Executive Officer | Sale+OE | 20,017 | $61.42 | $1,229,483.77 | -1.6% | |
| Dec 7, 2020 | Peltz Stuart Walter57 | Chief Executive Officer | Sale+OE | 348,417 | $61.00 | $21,254,765.91 | -17.8% | |
| Nov 4, 2020 | Jacobson Allan Steven51 | Director | Sale+OE | 20,000 | $60.00 | $1,200,000.00 | -85.1% | |
| Nov 4, 2020 | Peltz Stuart Walter57 | Chief Executive Officer | Sale+OE | 49,365 | $60.00 | $2,961,900.00 | -28.8% |